Gepotidacin or Zoliflodacin to Treat Gonorrhea

Antimicrobial resistant gonorrhea is a global public health concern. This episode discusses two articles evaluating two new antibiotics, gepotidacin and zoliflodacin, to treat uncomplicated urogenital gonorrhea. A retrospective study of WHO global gonococcal antimicrobial surveillance program (GASP) 2019-2022 data is also reviewed. View episode transcript and references at www.std.uw.edu.This podcast is dedicated to an STD [sexually transmitted disease] review for health care professionals who are interested in remaining up-to-date on the diagnosis, management, and prevention of STDs and STIs. Editor and host Dr. Meena Ramchandani is an Assistant Professor of Medicine at the University of Washington (UW), Program Director of the UW Infectious Diseases Fellowship Program, and Associate Editor of the National STD Curriculum.